Clinical manifestations in thrombotic children with factor V Leiden mutation

Pediatric Hematology and Oncology

Volumn 16, Issue 3, 1999, Pages 233-237

  Gurgey, Aytemiz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Factor V Leiden; Thrombosis in children

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ADOLESCENT; ARTICLE; BEHCET DISEASE; BLOOD CLOTTING; BRAIN INFARCTION; CHILD; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; HOMOCYSTINURIA; HOMOZYGOSITY; HUMAN; HYPEREOSINOPHILIA; INFANT; LEG AMPUTATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; RISK FACTOR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FACTOR V; FEMALE; HUMANS; INFANT; MALE; MUTATION; THROMBOSIS;

EID: 0032942757     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800199277281     Document Type: Article

References (16)

1. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67.
2. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood. 1995;85:1504-1508.
3. Nowak-Göttl U, Dübber A, Kececioglu D, et al. Factor V Leiden, protein C and lipoprotein (a) in cathether-related thrombosis in childhood: a prospective study. J Pediatr. 1997;131:608-612.
4. Uttenreuter-Fischer MM, Veiter B, Hellmann C, et al. Pediatric thromboembolism: the influence of non-genetic factors and the role of activated protein C resistance and protein C deficiency. Eur J Pediatr. 1997;156:277-281.
5. Manten B, Westendorp RGJ, Koster T, Reitsma PH, Rosendaal FR. Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation. Thromb Haemost. 1996;76:510-513.
6. Gurgey A, Mesci L, Renda Y, Olcay L, Kocak N, Erdem G. The factor V Q 506 mutation in children with thrombosis. Am J Hematol. 1996;53:37-39.
7. Gurgey A, Buyukpamukcu M, Baykurt C, Yalcin B, Gögüs S. Portal vein thrombosis in association with factor V Leiden mutation in a patient with hepatocellular carcinoma. Med Pediatr Oncol. 1997;29:224-225.
8. Olcay L, Gurgey A, Topaloglu H, Altay S, Parlak H, Firat M. Cerebral infarct associated with factor V Leiden mutation in a boy with hemophilia A. Am J Hematol. 1997;56:189-190.
9. Sackesen C, Secmeer G, Gurgey A, et al. Homozygous factor V Leiden mutation in a child with meningococcal purpura fulminans. Pediatr Infect Dis. 1998;17-87.
10. Gumruk F, Gurgey A, Altay C. A case of hypereosinophilic syndrome associated with factor V Leiden mutation and thrombosis. Br J Haematol. 1998;101:208-209.
11. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703.
12. Gurgey A, Hicsonmez G, Parlak H, Balta G. Celiker A. The prothrombin gene 20210 G-A mutation in Turkish patients with thrombosis. Am J Hematol. 1998;59:179-180.
13. Nowak-Göttl U, Koch HG, Aschka J, et al. Resistance to activated protein C (APCR) in children with venous or arterial thrombolism. Br J Haematol. 1996;92:992-998.
14. Sifontes MT, Nuss R, Jacobson LJ, Griffin JH, Manco-Johnson M. Thrombosis in otherwise well children with the factor V Leiden mutation. J Pediatr. 1996;128:324-328.
15. Martinelli J, Landi G, Merati G, Cella R, Tosetto A, Manucci M. Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost. 1997;393-394.
16. Sifontes MT, Nuss R, Hunger SP, Waters J, Jacobson LJ, Manco-Johnson M. Activated protein C resistance and the factor V Leiden mutation in children with thrombosis. Am J Hematol. 1998;57:29-32.